Get the Stockscreener App
47.37
0.11%
0.05
After Hours:
47.37
Spdr Pharmaceuticals Etf stock is traded at $47.37, with a volume of 31,620.
It is up +0.11% in the last 24 hours and up +1.87% over the past month.
See More
Previous Close:
$47.32
Open:
$47.57
24h Volume:
31,620
Relative Volume:
0.52
Market Cap:
$229.97M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-2.59%
1M Performance:
+1.87%
6M Performance:
+25.78%
1Y Performance:
+5.74%
1-Day Range:
$47.10
$47.57
1-Week Range:
$47.10
$48.84
52-Week Range:
$35.22
$49.31
Spdr Pharmaceuticals Etf Stock (XPH) Company Profile
Name
Spdr Pharmaceuticals Etf
Sector
Industry
Phone
-
Address
-
Compare XPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XPH
Spdr Pharmaceuticals Etf
|
47.37 | 229.97M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
326.93 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
663.04 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
666.23 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
253.06 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
602.01 | 124.43B | 0 | 0 | 0 | 0.00 |
Spdr Pharmaceuticals Etf Stock (XPH) Latest News
Short bets on S&P 500 Healthcare sector rises marginally to 1.91% in September; MRNA remains most shorted stock - Seeking Alpha
P Pharmaceuticals ETF stock protected from inflationJuly 2025 Final Week & Growth-Oriented Investment Plans - newser.com
4 Reasons to Buy Pharma ETFs Now for a Healthy Portfolio - sharewise.com
INCY and ABBV lead S&P 500 healthcare gainers in Q3; MOH and ALGN lag - MSN
Pharma stocks at 15-year valuation lows may offer value – BMO’s Evan Seigerman - Seeking Alpha
Headlines Boost Pharma Stocks. Charts of Pfizer, Johnson & Johnson, Jazz Pharmaceuticals Speak to Rally Into Year End - MSN
Headlines Boost Pharma Stocks. What the Charts of Pfizer, Johnson & Johnson, Jazz Pharmaceuticals Say - Barron's
P Pharmaceuticals ETF stock return to pre crash levelsWatch List & Safe Entry Point Identification - newser.com
P Pharmaceuticals ETF stock beat international competitionQuarterly Earnings Summary & Long-Term Safe Investment Ideas - newser.com
6 Best Health Care Funds and ETFs for 2025 - US News Money
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk - inkl
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms - Benzinga
P Pharmaceuticals ETF stock prepared for digital transitionTrade Analysis Summary & Capital Efficiency Focused Strategies - newser.com
Biopharma Stocks Rally After Trump Threatens 100% Pharmaceuticals Tariff - inkl
Trump Slams 100% Tariff on Imported Drugs: Pharma ETFs Take a Hit - Yahoo Finance
SPDR S&P Biotech ETF (XBI) Top 25 Holdings - TIKR.com
SPDR S&P Pharmaceuticals ETF $XPH Stake Boosted by Goldman Sachs Group Inc. - Defense World
Short bets on S&P 500 Healthcare sector eases in August; MRNA stays most shorted stock - Seeking Alpha
Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing - Benzinga
The Best Health Care ETFs to Buy - Kiplinger
XLV Vs. IHE: Will Pharmaceuticals Outperform Healthcare? (NYSEARCA:XLV) - Seeking Alpha
Simplex Trading LLC Buys Shares of 627 SPDR S&P Pharmaceuticals ETF $XPH - Defense World
Drug Tariffs Finally Land. Why Pharma Stocks Are Breathing Easy. - inkl
SPDR S&P Pharmaceuticals ETF $XPH Stock Position Reduced by Cetera Investment Advisers - Defense World
PJP: Healthcare Dashboard For August (NYSEARCA:PJP) - Seeking Alpha
Short bets on S&P 500 Healthcare sector ease in July; Moderna remains most heavily shorted stock - MSN
Market Voices: Bessent clarifies Fed comments, pharma tariffs, Target - Seeking Alpha
Blair William & Co. IL Buys Shares of 686 SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Should You Invest in the Health Care Select Sector SPDR ETF (XLV)? - Yahoo Finance
Blair William & Co. IL Purchases 251 Shares of Vanguard S&P Mid-Cap 400 ETF (NYSEARCA:IVOO) - Defense World
XTX Topco Ltd Invests $204,000 in SPDR S&P Bank ETF (NYSEARCA:KBE) - Defense World
LPL Financial LLC Decreases Stake in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Cetera Investment Advisers Increases Holdings in SPDR S&P Fossil Fuel Reserves Free ETF (NYSEARCA:SPYX) - Defense World
7 Best Biotech ETFs to Buy Now - US News Money
Investors Purchase High Volume of Call Options on SPDR S&P Regional Banking ETF (NYSEARCA:KRE) - Defense World
4. SPDR S&P Pharmaceuticals ETF (ARCA:XPH) - Investing News Network
Should You Invest in the SPDR S&P Biotech ETF (XBI)? - Yahoo Finance
PNC Financial Services Group Inc. Sells 917 Shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
Spdr Pharmaceuticals Etf Stock (XPH) Financials Data
There is no financial data for Spdr Pharmaceuticals Etf (XPH). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):